Traditional Chinese medicine composition for treating cognitive impairment with constipation after cerebral apoplexy and preparation method of traditional Chinese medicine composition
Through the use of traditional Chinese medicine composition, the problems of unstable efficacy and major side effects of treatment of constipation and cognitive impairment after stroke were solved, and significant relief of the disease and improvement of cognitive function were achieved.
Patent Information
- Application Number
- CN202410266470.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-08
- Publication Date
- 2024-11-15
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Common sequelae after stroke, constipation and cognitive impairment lack effective unified treatment methods. The existing drugs have unstable efficacy, poor compliance, large side effects and limited effects.
A Chinese medicine composition is adopted, consisting of ginseng, astragalus, Acorus granulated, Poria cocos, fried almonds, Cornus, Cooked Rehmannia, Angelica sinensis, Scutellaria baicalensis, Rhubarb, Citrus aurantium, Hemp Seed, Acorus granulated, Magnolia officinalis and Licorice Composition, prepared by soaking and decocting, forming powder or other dosage forms, and used orally.
It significantly improves cognitive function, relieves constipation, has few side effects, can effectively relieve the condition, and has significant efficacy. It is suitable for the treatment of cognitive impairment and constipation after stroke.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of traditional Chinese medicines, and in particular to a traditional Chinese medicine composition for treating post-stroke cognitive impairment combined with constipation and a preparation method thereof. Background Art
[0002] Stroke is a global public health problem and has become the leading cause of death and disability-adjusted life years in my country. With the acceleration of social aging and urbanization, and the change in residents' lifestyles, the incidence of stroke is increasing. What's more serious is that most patients after stroke are left with sequelae such as impaired consciousness, hemiplegia, dysphagia, and urination and defecation disorders.
[0003] Constipation and cognitive impairment are common sequelae after stroke. According to statistics, the incidence of constipation in patients in the acute phase of stroke is about 45%, and the incidence in the recovery phase is about 48%. Related studies have shown that the incidence of post-cerebrovascular cognitive impairment (PSCI) is 24%-53.4%, and it is also the leading risk factor for vascular dementia in stroke patients. The occurrence of the above two sequelae can prolong the hospitalization time of stroke patients, reduce the quality of life, increase the mortality rate of stroke patients, and further affect the brain function of patients, leading to worsening of stroke, bringing huge medical burden to patients.
[0004] Modern medicine believes that there is a bidirectional regulatory mechanism between the brain and the intestine, which is currently mainly called the brain-gut axis. It is mainly composed of the brain, intestine and intestinal microorganisms, and is a bidirectional traffic system that can control brain and intestinal functions. On the one hand, the intestinal flora can transmit information to the brain through neural pathways, neurotransmitter endocrine pathways, immune pathways, cell metabolites and host metabolic pathways. On the other hand, after brain damage occurs, the brain transmits signals to the intestine through the brain-gut axis, triggering intestinal inflammatory response, decreased intestinal motility, damaged intestinal mucosal barrier, increased intestinal permeability, and intestinal bacterial displacement. Studies have found that after ischemic stroke, the diversity of patients' intestinal flora decreases, the ratio of Bacteroidetes to Firmicutes changes, the abundance of beneficial bacteria such as Lactobacillus and Bifidobacterium decreases, and the abundance of opportunistic pathogenic bacteria such as Enterobacter increases. More and more evidence shows that there is a mutually influential and mutually beneficial symbiotic relationship between the intestine and the brain. The common symptoms of gastrointestinal dysfunction include vomiting, abdominal distension, diarrhea, anorexia, constipation, etc. These patients are often accompanied by neurological symptoms such as anxiety, insomnia, neurasthenia, headache, etc. After brain injuries such as stroke, they are often accompanied by abnormal gastrointestinal function, with symptoms such as vomiting and constipation.
[0005] At present, the clinical treatment of post-stroke constipation and cognitive impairment mainly relies on symptomatic drug therapy, and there is no unified and effective method for the clinical treatment of such patients; the commonly used drugs for the treatment of post-stroke constipation mainly include osmotic laxatives, softeners, and stimulant laxatives, such as lactulose and enema; the treatment of post-stroke cognitive impairment mainly includes oxiracetam, piracetam, donepezil, memantine hydrochloride, etc.; however, the above drugs have disadvantages such as unstable efficacy, poor compliance, large adverse reactions, and limited effects during the treatment process. Summary of the invention
[0006] As a special medical system in my country, traditional Chinese medicine has the characteristics of holistic concept and syndrome differentiation and treatment, which can adjust the functional state of the human body as a whole and achieve a stable state of yin-yang balance and organ coordination. The present invention aims at the defects of existing drugs in the treatment process, such as unstable efficacy, poor compliance, large adverse reactions and limited effects, and proposes a Chinese medicine composition and preparation method for treating post-stroke cognitive impairment combined with constipation, and the clinical application effect is significant.
[0007] The technical solution of the present invention:
[0008] A traditional Chinese medicine composition for treating post-stroke cognitive impairment accompanied by constipation, comprising the following raw materials in parts by weight: 6-9 parts of ginseng, 9-20 parts of astragalus, 6-9 parts of polygala, 6-15 parts of calamus, 10-30 parts of tuckahoe, 6-9 parts of stir-fried apricot kernel, 6-15 parts of cornus officinalis, 15-30 parts of prepared rehmannia, 6-20 parts of angelica, 6-15 parts of alpinia oxyphylla, 10-20 parts of scutellaria, 6-12 parts of rhubarb, 10-20 parts of immature bitter orange, 15-30 parts of hemp seed, 6-12 parts of calamus, 10-20 parts of magnolia bark and 6-12 parts of liquorice.
[0009] Preferably, it is composed of the following raw materials in parts by weight: 9 parts of ginseng, 15 parts of astragalus, 6 parts of polygala, 9 parts of calamus, 15 parts of poria, 9 parts of stir-fried apricot kernel, 15 parts of cornus, 30 parts of prepared rehmannia, 15 parts of angelica, 9 parts of alpinia oxyphylla, 15 parts of scutellaria, 9 parts of rhubarb, 15 parts of immature bitter orange, 30 parts of hemp seed, 9 parts of calamus, 15 parts of magnolia bark and 6 parts of liquorice.
[0010] The present invention also provides a medicine for treating post-stroke cognitive impairment combined with constipation of the Qi-deficiency and phlegm-blockage type, wherein the medicine is prepared from the above-mentioned traditional Chinese medicine composition and pharmaceutically acceptable excipients.
[0011] A method for preparing a traditional Chinese medicine composition for treating post-stroke cognitive impairment accompanied by constipation comprises the following steps:
[0012] S1. Take each raw material medicine according to the ratio: ginseng, astragalus, polygala, calamus, poria, stir-fried apricot kernel, cornus officinalis, rehmannia, angelica, alpinia oxyphylla, scutellaria baicalensis, rhubarb, immature bitter orange, hemp seed, calamus, magnolia bark and licorice, soak in water for 1 hour, and the water should cover the raw materials;
[0013] S2, add 8 times the weight of the raw material drug to the soaked raw material drug, decoct for 2 hours, filter after decoction, and obtain the first filtrate and the first filter residue;
[0014] S3, add 8 times the weight of the raw material drug to the first filter residue, boil for 2 hours, and filter to obtain the second filtrate and the second filter residue;
[0015] S4. Combine the first filtrate and the second filtrate.
[0016] Preferably, the method further comprises: S5, the first filtrate and the second filtrate are allowed to stand for 1-2 hours, the supernatant is taken and compressed into a thick paste with a relative density of 1.3-1.4, dextrin is added and mixed, and powder is prepared and packaged.
[0017] Preferably, the relative density is the density of the thick paste relative to water at 60°C.
[0018] Preferably, the concentration pressure is 0.06-0.08 MPa.
[0019] Preferably, the weight ratio of dextrin to thick paste is 4:2.
[0020] Preferably, S5 is made into powder by spray drying.
[0021] Preferably, S5 is prepared into granules, powders, capsules, tablets or mixtures.
[0022] Solution:
[0023] This prescription is modified from Kaixinsan (Sun Simiao in Qianjin Fang, Tang Dynasty), Xiaochengqi Decoction (Zhang Zhongjing in Shanghan Lun, Han Dynasty), and Runchang Decoction (Gong Tingxian in Wanbing Huichun, Ming Dynasty). Ginseng is sweet and slightly warm in nature, enters the lung, spleen, and heart meridians, and is mainly used to replenish vital energy, calm the mind and improve intelligence. Astragalus is sweet and slightly warm, and enters the spleen and lung meridians, and is mainly used to replenish qi and strengthen the spleen. It is an important medicine for tonifying the middle and replenishing qi. The two are used together to play the role of replenishing qi and raising the clearness.
[0024] Cornus officinalis is sour and astringent, and enters the liver and kidney meridians, mainly tonifying the liver and kidneys; Rehmannia glutinosa is sweet and warm, and enters the liver and kidney meridians, mainly tonifying blood and nourishing yin, replenishing essence and benefiting marrow, and is an important medicine for tonifying kidney yin; Alpinia oxyphylla is pungent and warm, and enters the kidney and spleen meridians, warming the kidney and consolidating essence, warming the spleen and stimulating appetite; the three medicines are used together to jointly exert the effect of tonifying kidney essence, producing marrow and filling the brain.
[0025] Poria is sweet and light, and enters the heart, spleen, and kidney meridians. It mainly strengthens the spleen and calms the mind. Acorus calamus is pungent and warm, and enters the heart and stomach meridians. It has the functions of opening the orifices and refreshing the mind, resolving turbidity and eliminating filth, and is good at treating unconsciousness caused by dampness and turbidity obscuring the clear orifices; Polygala tenuifolia is pungent and warm, and can remove phlegm, open the orifices, calm the mind and improve intelligence; Magnolia officinalis is a drier and more effective in drying dampness and eliminating phlegm. The four herbs work together to strengthen the spleen, remove dampness and resolve turbidity, and open the orifices and refresh the mind.
[0026] Turbid evil is blocked inside the body, and the function of descending and ascending is disordered, which causes constipation. Turbid evil is blocked for a long time, and the detoxification damages the internal organs. Therefore, the prescription uses rhubarb to cleanse the intestines and stomach, and remove turbidity and usher in newness; hemp seed moistens the intestines and promotes bowel movements; angelica and fried apricot kernels promote blood circulation and remove blood stasis, moisten the intestines and promote bowel movements; scutellaria baicalensis clears away heat and detoxifies, and together they play the role of clearing the bowels, removing turbidity, and removing blood stasis and detoxifying.
[0027] It is supplemented with Zhishi to break up qi and eliminate stagnation, resolve phlegm and eliminate lumps; Magnolia officinalis is used to reduce qi and eliminate fullness; the two medicines work together to help the smooth flow of qi in the intestines and organs, and help eliminate stasis and turbidity. Licorice is a guiding medicine, which nourishes the spleen and replenishes qi and harmonizes the other medicines. The whole prescription uses both cold and warm, attacks and supplements at the same time, raises the clear and clears the turbid, and works together to reverse the qi mechanism, restore the state of coordinated balance between the rise and fall of the clear and turbid, so that qi and blood can flow smoothly, the brain is nourished, the turbidity is eliminated, and cognitive function can be restored.
[0028] Usage and dosage of the present invention:
[0029] For oral administration, 10g of powder at a time, take with 100-200ml of warm water; 10g of granules, powders, capsules, and tablets at a time, swallow with warm water; mixture or decoction, take 2-3 times a day according to doctor's orders, 14 days as a course of treatment, it is recommended to take orally for 4-6 courses of treatment or follow the doctor's orders.
[0030] During the administration of the Chinese medicine composition of the invention, greasy, spicy, raw, cold and other irritating foods are contraindicated.
[0031] Beneficial effects of the present invention:
[0032] The present invention regulates the brain-gut axis as a whole, thereby improving cognitive function and relieving constipation, which can effectively alleviate the condition with little side effects.
[0033] The present invention is based on the "clear and turbid theory" of traditional Chinese medicine and the brain-gut axis theory of Western medicine. Although Western medicine classifies cognitive impairment and constipation as two diseases, according to the theory of traditional Chinese medicine, the two can be closely linked. The theory of clear and turbid was first proposed in the "Yellow Emperor's Internal Classic". It is an important concept in the basic theory of traditional Chinese medicine and has been widely extended by later doctors. It is used in analyzing etiology and pathogenesis, explaining pathological physiological processes, describing symptoms and syndromes, determining treatment principles and methods, etc., forming a rich theoretical system; "Suwen·Yin Yang Ying Xiang Da Lun Pian" "clear yang is the sky, turbid yin is the earth" and "clear yang comes out of the upper orifices, turbid yin comes out of the lower orifices", which shows that "clear and turbid" not only represent specific substances produced by the environment and the body, but also contain the movement of qi "clear rises and turbid falls".
[0034] First of all, clear and turbid represent the basic form of the movement of qi in the body. "Clear yang rises, turbid yin descends." According to TCM theory, clear qi is yang and belongs to the upper part, while turbid qi is yin and belongs to the lower part. On the contrary, it will cause disease. "When clear qi is at the lower part, diarrhea will occur; when turbid qi is at the upper part, bloating will occur." In the clear and turbid qi, the spleen and stomach are particularly important. The spleen and stomach are the hubs of the body's qi movement. The spleen is responsible for ascending the clear qi, and the stomach is responsible for descending the turbid qi. When the viscera function is abnormal, the qi movement is out of balance, the clear qi does not rise, the brain is not nourished, and the turbid evil invades the clear orifices, damaging the brain, causing brain diseases with cognitive impairment. At the same time, the turbid evil turns into poison over time, further damaging the brain nerves. When the turbid evil does not descend, it stagnates in the intestines, causing constipation and other intestinal diseases. "Treatise on Febrile Diseases" mentions that "in Yangming disease, the stomach is dry, and the stool must be hard, and hard stools cause delirium." This explains why gastrointestinal diseases cause nervous system diseases from the perspective of TCM theory.
[0035] Secondly, clear and turbid represent the essence of water and grain and the waste of food in the human body. "Clear yang fills the limbs, turbid yin returns to the six internal organs", which shows that "clear" represents the essence of water and grain in the human body, and "turbid" represents the waste after metabolism; the kidney is the "innate foundation", and the spleen and stomach are the "acquired foundation". The kidney stores essence, controls bone marrow, and the marrow fills the brain, and the brain is the sea of marrow. "The kidney is below, and the brain is above. If they are weak, they are all weak" ("Yi Ji·Volume 4"), which shows the close relationship between the brain and the kidney. The normal function of the brain is inseparable from the nourishment of kidney essence and kidney qi, and kidney qi and kidney essence can be attributed to the "innate clearness" of the human body. "The spleen and stomach are the acquired foundation, the source of qi and blood production", the spleen is responsible for ascending the clear, distributing the essence of water and grain throughout the body, and transmitting metabolic waste to the outside of the body through the gastrointestinal tract. Therefore, the water and grain essence transported by the spleen and stomach can be attributed to the "acquired clearness" of the human body. From this, it can be seen that the movement of clearness and turbidity in the human body is closely related to the functions of the spleen, kidney, stomach, large intestine, small intestine and other internal organs.
[0036] The main location of stroke and cognitive impairment is the brain, while constipation is mainly in the large intestine. Although they belong to two different organs and two different diseases, they are closely related in function. The brain is the home of the soul, and is responsible for the life, spirit, and sensation of the human body. The normal activities of the large intestine are also inseparable from the regulation of the brain. In addition, the brain and the large intestine are closely connected in terms of meridians. The hand yangming meridian tendons "go up the forehead and connect to the head". When the function of the brain is damaged, the normal function of the spleen, stomach, and large intestine will inevitably be affected, resulting in the disorder of the qi of the internal organs, the disorder of the rise and fall of the clear and turbid, the correlation of the clear and turbid, and the obstruction of the qi of the internal organs, causing various gastrointestinal diseases. This is also the theoretical basis for the fact that stroke patients are often accompanied by gastrointestinal symptoms such as constipation. At the same time, the obstruction of the qi of the internal organs, the failure of the clear yang to rise, and the malnutrition of the brain marrow will inevitably affect the normal physiological function of the brain and cause various brain disorders. Therefore, by regulating the clear and turbid qi of the body and restoring it to a good state of balance of rise and fall, the brain and intestinal functions of the body can be effectively improved. DETAILED DESCRIPTION
[0037] In order to further explain the technical means and effects adopted by the present invention to achieve the predetermined invention purpose, the specific implementation method, structure, characteristics and effects of the present invention are described in detail below in combination with the preferred embodiments.
[0038] Embodiment 1
[0039] A Chinese medicine composition for treating post-stroke cognitive impairment combined with constipation, comprising the following Chinese medicine composition in parts by weight:
[0040] 9 parts of ginseng, 15 parts of astragalus, 6 parts of polygala, 15 parts of calamus, 15 parts of tuckahoe, 8 parts of stir-fried apricot kernel, 15 parts of cornus officinalis, 30 parts of rehmannia prepared, 6 parts of angelica, 15 parts of alpinia oxyphylla, 15 parts of scutellaria baicalensis, 12 parts of rhubarb, 10 parts of immature bitter orange, 30 parts of canna seed, 12 parts of calamus, 15 parts of magnolia bark and 12 parts of liquorice.
[0041] Embodiment 2
[0042] A Chinese medicine composition for treating post-stroke cognitive impairment combined with constipation, comprising the following Chinese medicine composition in parts by weight:
[0043] 6 parts of ginseng, 12 parts of astragalus, 6 parts of polygala, 12 parts of calamus, 20 parts of tuckahoe, 9 parts of stir-fried apricot kernel, 10 parts of cornus officinalis, 20 parts of rehmannia prepared, 12 parts of angelica, 9 parts of alpinia oxyphylla, 10 parts of scutellaria baicalensis, 6 parts of rhubarb, 15 parts of immature bitter orange, 15 parts of canna seed, 9 parts of calamus, 10 parts of magnolia bark and 9 parts of liquorice.
[0044] Embodiment 3
[0045] A Chinese medicine composition for treating post-stroke cognitive impairment combined with constipation, comprising the following Chinese medicine composition in parts by weight:
[0046] 9 parts of ginseng, 10 parts of astragalus, 9 parts of polygala, 9 parts of calamus, 12 parts of tuckahoe, 6 parts of stir-fried apricot kernel, 10 parts of cornus officinalis, 15 parts of rehmannia, 10 parts of angelica, 9 parts of alpinia oxyphylla, 20 parts of scutellaria, 6 parts of rhubarb, 12 parts of immature bitter orange, 30 parts of hemp seed, 9 parts of calamus, 12 parts of magnolia bark and 9 parts of liquorice.
[0047] Embodiment 4
[0048] A Chinese medicine composition for treating post-stroke cognitive impairment combined with constipation, comprising the following Chinese medicine composition in parts by weight:
[0049] 7 parts of ginseng, 12 parts of astragalus, 8 parts of polygala, 9 parts of calamus, 30 parts of tuckahoe, 9 parts of stir-fried apricot kernel, 6 parts of cornus officinalis, 20 parts of rehmannia, 20 parts of angelica, 6 parts of alpinia oxyphylla, 10 parts of scutellaria, 6 parts of rhubarb, 20 parts of immature bitter orange, 15 parts of hemp seed, 6 parts of calamus, 20 parts of magnolia bark and 6 parts of liquorice.
[0050] Embodiment 5
[0051] A Chinese medicine composition for treating post-stroke cognitive impairment combined with constipation, comprising the following Chinese medicine composition in parts by weight:
[0052] 6 parts of ginseng, 9 parts of astragalus, 9 parts of polygala, 6 parts of calamus, 12 parts of tuckahoe, 6 parts of stir-fried apricot kernel, 10 parts of cornus, 20 parts of rehmannia, 12 parts of angelica, 9 parts of alpinia oxyphylla, 12 parts of scutellaria, 6 parts of rhubarb, 12 parts of immature bitter orange, 20 parts of canna seed, 9 parts of calamus, 12 parts of magnolia bark and 9 parts of liquorice.
[0053] Embodiment 6
[0054] A Chinese medicine composition for treating post-stroke cognitive impairment combined with constipation, comprising the following Chinese medicine composition in parts by weight:
[0055] 6 parts of ginseng, 20 parts of astragalus, 6 parts of polygala, 9 parts of calamus, 12 parts of tuckahoe, 9 parts of stir-fried apricot kernel, 12 parts of cornus, 30 parts of rehmannia, 10 parts of angelica, 9 parts of alpinia oxyphylla, 10 parts of scutellaria, 9 parts of rhubarb, 12 parts of immature bitter orange, 30 parts of canna seed, 9 parts of calamus, 15 parts of magnolia bark and 9 parts of liquorice.
[0056] The preparation methods of Examples 1-6 of the present invention are all:
[0057] A method for preparing a traditional Chinese medicine composition for treating post-stroke cognitive impairment accompanied by constipation comprises the following steps:
[0058] S1. Take each raw material medicine according to the ratio: ginseng, astragalus, polygala, calamus, poria, stir-fried apricot kernel, cornus officinalis, rehmannia, angelica, alpinia oxyphylla, scutellaria baicalensis, rhubarb, immature bitter orange, hemp seed, calamus, magnolia bark and liquorice, add water and soak for 1 hour, the water covers the raw materials;
[0059] S2, add 8 times the weight of the raw material drug to the soaked raw material drug, decoct for 2 hours, filter after decoction, and obtain the first filtrate and the first filter residue;
[0060] S3, add 8 times the weight of the raw material drug to the first filter residue, boil for 2 hours, and filter to obtain the second filtrate and the second filter residue;
[0061] S4, combining the first filtrate and the second filtrate;
[0062] S5. The first filtrate and the second filtrate are allowed to stand for 1.5 hours, and the supernatant is concentrated to a thick paste with a hydraulic pressure of 0.06-0.08 MPa and a density of 1.3-1.4 relative to 60°C water. The weight ratio of dextrin to thick paste is 4:2. Dextrin is added and mixed, and the powder is made into powder by spray drying and packaged.
[0063] The first embodiment is made into powder, the second embodiment is pressed into tablets, the third embodiment is pressed into granules, the fourth embodiment is made into granules and capsules, the fifth embodiment is made into powders with auxiliary materials, and the sixth embodiment is packed into bags, each bag has 10g.
[0064] Embodiment 7 Decoction
[0065] A Chinese medicine composition for treating post-stroke cognitive impairment combined with constipation, comprising the following Chinese medicine composition in parts by weight:
[0066] 9 parts of ginseng, 15 parts of astragalus, 6 parts of polygala, 9 parts of calamus, 15 parts of tuckahoe, 9 parts of stir-fried apricot kernel, 15 parts of cornus officinalis, 30 parts of prepared rehmannia, 15 parts of angelica, 9 parts of alpinia oxyphylla, 15 parts of scutellaria baicalensis, 9 parts of rhubarb, 15 parts of immature bitter orange, 30 parts of canna seed, 9 parts of calamus, 15 parts of magnolia bark and 6 parts of liquorice.
[0067] Preparation method:
[0068] S1. Take each raw material medicine according to the ratio: ginseng, astragalus, polygala, calamus, poria, stir-fried apricot kernel, cornus officinalis, rehmannia, angelica, alpinia oxyphylla, scutellaria baicalensis, rhubarb, immature bitter orange, hemp seed, calamus, magnolia bark and liquorice, add water and soak for 1 hour, the water covers the raw materials;
[0069] S2, add 8 times the weight of the raw material drug to the soaked raw material drug, decoct for 2 hours, filter after decoction, and obtain the first filtrate and the first filter residue;
[0070] S3, add 8 times the weight of the raw material drug to the first filter residue, boil for 2 hours, and filter to obtain the second filtrate and the second filter residue;
[0071] S4. Combine the first filtrate and the second filtrate, divide into bags, 200 mL per bag, and seal for storage.
[0072] Clinical application of the present invention
[0073] 1. Research subjects
[0074] 1.1 General Information
[0075] The subjects were 66 patients with post-stroke cognitive impairment and constipation admitted to the Department of Rehabilitation Medicine of Shijiazhuang People's Hospital from May 2023 to December 2023. After meeting the criteria for inclusion in the trial, they were randomly divided into an experimental group of 33 cases and a control group of 33 cases. There was no statistical difference in baseline data such as age, gender, course of disease, and stroke type between the two groups of patients (P>0.05) (see the table below).
[0076]
[0077] 1.2 Diagnostic criteria
[0078] 1.2.1 Western medicine diagnostic criteria
[0079] (1) Patients were diagnosed with stroke according to the Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China (2018), the Guidelines for the Diagnosis and Treatment of Cerebral Infarction in China (2018), and the Guidelines for the Diagnosis and Treatment of Cerebral Hemorrhage in China (2019). All cases were confirmed by CT or MRI and were in the recovery period of stroke;
[0080] (2) Refer to the Expert Consensus on the Management of Post-stroke Cognitive Impairment (2021) for patients who meet the criteria for post-stroke cognitive impairment (PSCI). (3) Refer to the 2006 International Functional Gastrointestinal Disorders (FGIDS)-Rome III diagnostic criteria:
[0081] ① Straining during bowel movements (at least 1 out of every 4 bowel movements).
[0082] ② The stool is lumpy or hard (at least 1 out of every 4 bowel movements).
[0083] ③ Feeling of incomplete defecation (at least once in every 4 bowel movements).
[0084] ④ There is anorectal obstruction and / or a feeling of blockage (at least once in every 4 bowel movements).
[0085] ⑤ Manual manipulation (such as finger-assisted defecation, pelvic floor support defecation) is required to promote defecation (at least 1 out of every 4 bowel movements).
[0086] ⑥ Bowel movements less than 3 times a week.
[0087] 1.2.2 TCM diagnostic criteria
[0088] (1) Patients diagnosed with stroke according to the "Standards for Diagnosis and Therapeutic Effect Evaluation of Stroke (Trial)": a. Main symptoms: hemiplegia, confusion, slurred speech or silence, paresthesia on one side of the body, crooked mouth and tongue. b. Secondary symptoms: headache, dizziness, pupil changes, choking when drinking water, unblinking eyes, ataxia. c. Onset: acute onset, often with triggers and often with premonitory symptoms. d. Age of onset: mostly over 40 years old.
[0089] If the patient has two or more main symptoms, or one main symptom plus two secondary symptoms, the diagnosis can be confirmed by combining the onset, triggering factors, precursor symptoms, and age. If the above conditions are not met, the diagnosis can also be confirmed by combining the results of imaging examinations.
[0090] (2) At present, there is no clear diagnostic standard for post-stroke cognitive impairment in traditional Chinese medicine. With reference to the content on dementia and amnesia in the "Chinese Internal Medicine (Eighth Edition)", post-stroke cognitive impairment is included in the category of dementia and amnesia. The key points of diagnosis are: memory loss, decreased ability to remember recent and distant events, decreased ability to recognize people, objects, time, and place, decreased ability to calculate and recognize spatial location structure, and impaired ability to understand other people's language and answer questions in an orderly manner as the main symptoms.
[0091] (3) Refer to the diagnostic criteria for “constipation” in the “Standards for Diagnosis and Efficacy of TCM Diseases and Syndromes” issued by the State Administration of Traditional Chinese Medicine in 1994:
[0092] ① Defecation time is prolonged, occurring more than once every two days, and the stool is dry and hard.
[0093] ② In severe cases, defecation is difficult and dry like chestnuts, and may be accompanied by lower abdominal distension, fatigue, and decreased appetite.
[0094] ③ Rule out organic intestinal diseases.
[0095] 1.3 Inclusion criteria
[0096] ① Meet the diagnostic criteria of traditional Chinese and Western medicine for stroke, cognitive impairment and constipation;
[0097] ②Meet the diagnostic criteria for post-stroke cognitive impairment;
[0098] ③ Aged between 40 and 70 years old;
[0099] ④ The stroke is in the recovery stage, with a course of 2 weeks to 6 months;
[0100] ⑤ The patient's vital signs are stable and there are no factors affecting the score such as unconsciousness;
[0101] ⑥ Voluntarily participate in the study and sign the informed consent;
[0102] 1.4 Exclusion criteria
[0103] ① Constipation caused by organic intestinal lesions (tumors, tuberculosis, polyps, etc.);
[0104] ②Severe complications of heart, liver, kidney, etc.;
[0105] ③ Those who suffer from mental illness and cannot cooperate with treatment;
[0106] ④ Patients with a history of constipation before stroke;
[0107] ⑤ Patients with cognitive impairment before stroke;
[0108] ⑥ Patients whose cognitive function cannot be assessed due to impaired consciousness;
[0109] 1.5 Rejection and shedding standards
[0110] ① Patients who have not received clinical observation according to relevant regulations and whose efficacy cannot be assessed as planned;
[0111] ② Patients with insufficient clinical treatment course;
[0112] ③ Patients who voluntarily withdraw from clinical treatment;
[0113] ④ Those with poor compliance, not following treatment regulations, or unable to complete treatment;
[0114] ⑤ Patients who are unwilling to continue clinical observation during the trial.
[0115] 1.6 Termination criteria
[0116] ① Those who experience severe adverse reactions during treatment;
[0117] ② Patients with other serious complications such as heart, liver and kidney during treatment;
[0118] ③Those who request to stop the trial or withdraw from the trial on their own during the treatment process;
[0119] ④ Those who are discharged from the hospital, transferred to another hospital, or die during the treatment process;
[0120] 2. Intervention methods
[0121] All enrolled patients were given basic treatment for stroke, including but not limited to antiplatelet aggregation, lipid-lowering and platelet stabilization, blood pressure control, blood sugar control, etc.
[0122] All patients enrolled in the group were given cognitive dysfunction training treatment in the rehabilitation department, mainly including attention training (visual attention, auditory attention training, attention allocation, attention switching training), memory (short-term memory such as N-BACK training, short-text memory recall training), etc.
[0123] 2.1 Experimental Group
[0124] On the basis of the above treatment, the Chinese medicine composition of Example 6 is administered for oral treatment:
[0125] Dosage: Oral administration, 1 bag each time, 2 times a day, take with 100-200ml warm water.
[0126] 2.2 Control group
[0127] On the basis of basic treatment and cognitive rehabilitation therapy, donepezil hydrochloride (Eisai) was given at a dose of 5 mg / tablet, once a day, 5 mg each time, orally before bedtime.
[0128] 2.3 Treatment duration: The intervention time of this clinical observation is 8 weeks.
[0129] 3. Observation indicators
[0130] (1) Mini-Mental State Examination (MMSE): It is a commonly used scale for screening cognitive function in clinical practice. It can comprehensively, accurately and quickly reflect the intellectual status and degree of cognitive impairment of the subjects, and provide a scientific basis for clinical psychology diagnosis, treatment and neuropsychology research. This scale is simple and easy to use, widely used at home and abroad, and is the preferred scale for dementia screening. This scale includes the following 7 aspects: time orientation, place orientation, immediate memory, attention and calculation ability, delayed memory, language, and visual space. There are 30 questions in total. Each correct answer is scored 1 point, and an incorrect answer or an unknown answer is scored 0 points. The total score range of the scale is 0-30 points. The test score is closely related to the cultural level. The normal boundary value is divided as follows: illiterate >17 points, primary school >20 points, junior high school and above >24 points.
[0131] (2) Montreal Cognitive Assessment (MoCA): It is an assessment tool used to quickly screen for cognitive dysfunction. It includes 11 examination items in eight cognitive areas, including attention and concentration, executive function, memory, language, visual construction skills, abstract thinking, calculation and orientation. The total score is 30 points, and a score of ≥26 points is normal. It has high sensitivity, covers important cognitive areas, and has a short test time, making it suitable for clinical application.
[0132] (3) National Institutes of Health Stroke Scale (NIHSS): It is a clinical scale used to assess the degree of neurological deficit after stroke. It has high reliability and validity, with an internal consistency of 0.95. It is widely used in clinical practice. It includes 10 items, including level of consciousness (7 points), gaze (2 points), visual field loss (3 points), facial paralysis (3 points), limb movement disorder (16 points), ataxia (2 points), sensation (2 points), language (3 points), dysarthria (2 points), and neglect (2 points). The total score is 42 points. A score of ≤ 4 points indicates mild stroke, 5 to 15 points indicates moderate stroke, and 16 to 42 points indicates severe stroke. The higher the score, the more severe the neurological deficit.
[0133] (4) Patient Assessment of Consipation Symptom Questionnaire (PAC-SYM, see Table 1): This questionnaire consists of three parts: stool characteristics, rectal symptoms, and abdominal symptoms, with a total of 12 items. It can review the patient's constipation symptoms in the past 2 weeks. Current studies have examined its validity and reliability, and the results have shown that it has good reliability and validity and can effectively reflect the treatment effect.
[0134] (5) TCM syndrome score evaluation: refer to the 2002 "Guidelines for Clinical Research of New Chinese Medicines", and use the nimodipine method to score: the calculation formula is: (pre-treatment score - post-treatment score) / pre-treatment score x 100%. Cured: symptoms or signs disappeared or almost disappeared, and the score decreased by ≥ 95%. Significantly effective: symptoms or signs improved significantly, 70% ≤ score decreased < 95%. Effective: symptoms or signs improved, 30% ≤ score decreased < 70%. Ineffective: symptoms or signs did not improve significantly, and the score decreased < 30%.
[0135] 4. Results
[0136] During the treatment, 2 patients dropped out of the experimental group (1 patient stopped the trial due to discharge, and 1 patient adopted other treatment methods on his own), and 1 patient dropped out of the control group (stopped the trial due to discharge). Results A total of 63 patients completed the trial, with a completion rate of 95.45%.
[0137] 4.1 Changes in PAC-SYM scores before and after treatment in the two groups
[0138]
[0139] The results showed that there was no statistical difference in PAC-SYM scores between the two groups of patients before treatment (P>0.05). After 8 weeks of treatment, the scores of both the experimental group and the control group decreased compared with before treatment, and the difference was statistically significant (P<0.01), and the experimental group was better than the control group (P<0.05).
[0140] 4.2 Changes in NIHSS scores before and after treatment in the two groups
[0141]
[0142]
[0143] The results showed that there was no statistical difference in NIHSS scores between the two groups of patients before treatment (P>0.05). After 8 weeks of treatment, the scores of both the experimental group and the control group decreased compared with before treatment, and the difference was statistically significant (P<0.01), and the experimental group was better than the control group (P<0.05).
[0144] 4.3 Changes in MMSE scores in the two groups before and after treatment
[0145]
[0146] The results showed that there was no statistical difference in MMSE scores between the two groups of patients before treatment (P>0.05). After 8 weeks of treatment, the scores of both the experimental group and the control group decreased compared with before treatment, and the difference was statistically significant (P<0.01), and the experimental group was better than the control group (P<0.05).
[0147] 4.4. Changes in MoCa scores in the two groups before and after treatment
[0148]
[0149]
[0150] The results showed that there was no statistical difference in MoCa scores between the two groups of patients before treatment (P>0.05). After 8 weeks of treatment, the scores of both the experimental group and the control group decreased compared with before treatment, and the difference was statistically significant (P<0.01), and the experimental group was better than the control group (P<0.05).
[0151] 4.5 Comparison of effective rates between the two groups
[0152] After 8 weeks of treatment, the results showed that in the experimental group, 3 cases were cured, 23 cases were improved, 5 cases were ineffective, and the total effective rate was 83.87%. In the control group, 1 case was cured, 19 cases were improved, 12 cases were ineffective, and the effective rate was 62.5%.
[0153]
[0154] After performing a rank sum test on the efficacy of the two groups, the results showed that Z=-2.045, P<0.05, indicating that there was a statistically significant difference in the efficacy between the two groups, and the experimental group was better than the control group.
[0155] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. Although the present invention has been disclosed as a preferred embodiment as above, it is not used to limit the present invention. Any technical personnel in this field can make some changes or modify the technical contents disclosed above into equivalent embodiments without departing from the scope of the technical solution of the present invention. However, any brief modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention without departing from the content of the technical solution of the present invention are still within the scope of the technical solution of the present invention.
Claims
1. A Chinese medicine composition for treating post-stroke cognitive impairment accompanied by constipation, characterized in that: The invention is composed of the following raw materials in parts by weight: 6-9 parts of ginseng, 9-20 parts of astragalus, 6-9 parts of polygala, 6-15 parts of calamus, 10-30 parts of tuckahoe, 6-9 parts of fried apricot kernel, 6-15 parts of cornus officinalis, 15-30 parts of rehmannia root, 6-20 parts of angelica, 6-15 parts of alpinia oxyphylla, 10-20 parts of scutellaria baicalensis, 6-12 parts of rhubarb, 10-20 parts of immature bitter orange, 15-30 parts of hemp seed, 6-12 parts of calamus, 10-20 parts of magnolia bark and 6-12 parts of liquorice.
2. A Chinese medicine composition for treating post-stroke cognitive impairment with constipation according to claim 1, characterized in that: The medicine is composed of the following raw materials in parts by weight: 9 parts of ginseng, 15 parts of astragalus, 6 parts of polygala, 9 parts of calamus, 15 parts of poria, 9 parts of stir-fried apricot kernel, 15 parts of cornus, 30 parts of rehmannia, 15 parts of angelica, 9 parts of alpinia oxyphylla, 15 parts of scutellaria, 9 parts of rhubarb, 15 parts of immature bitter orange, 30 parts of hemp seed, 9 parts of calamus, 15 parts of magnolia bark and 6 parts of liquorice.
3. A method for preparing a Chinese medicine composition for treating post-stroke cognitive impairment accompanied by constipation, characterized in that: The following steps are involved: S1. Take each raw material medicine according to the ratio: ginseng, astragalus, polygala, calamus, poria, stir-fried apricot kernel, cornus officinalis, rehmannia, angelica, alpinia oxyphylla, scutellaria baicalensis, rhubarb, immature bitter orange, hemp seed, calamus, magnolia bark and licorice, soak in water for 1 hour, and the water should cover the raw materials; S2, add 8 times the weight of the raw material drug to the soaked raw material drug, decoct for 2 hours, filter after decoction, and obtain the first filtrate and the first filter residue; S3, add 8 times the weight of the raw material drug to the first filter residue, boil for 2 hours, and filter to obtain the second filtrate and the second filter residue; S4. Combine the first filtrate and the second filtrate.
4. The method for preparing a Chinese medicine composition for treating post-stroke cognitive impairment with constipation according to claim 3, characterized in that: The method also includes allowing S5, the first filtrate and the second filtrate to stand for 1-2 hours, taking the supernatant and compressing it into a thick paste with a relative density of 1.3-1.4, adding dextrin and mixing well to prepare a powder, and packaging it.
5. The method for preparing a Chinese medicine composition for treating post-stroke cognitive impairment with constipation according to claim 4, characterized in that: The relative density is the density of the thick paste relative to 60°C water.
6. The method for preparing a Chinese medicine composition for treating post-stroke cognitive impairment with constipation according to claim 4, characterized in that: The concentration pressure is 0.06-0.08MPa.
7. The method for preparing a Chinese medicine composition for treating post-stroke cognitive impairment with constipation according to claim 4, characterized in that: The weight ratio of dextrin: thick paste is 4:
2.
8. The method for preparing a Chinese medicine composition for treating post-stroke cognitive impairment with constipation according to claim 4, characterized in that: S5 was prepared into powder by spray drying.
9. The method for preparing a Chinese medicine composition for treating post-stroke cognitive impairment with constipation according to claim 4, characterized in that: S5 is made into granules, powders, capsules, tablets or mixtures.
Citation Information
Patent Citations
Traditional Chinese medicine preparation for treating poststroke depression and preparation method of traditional Chinese medicine preparation
CN105497789A
Traditional Chinese medicine materials and traditional Chinese medicine preparation for preventing Alzheimer's disease, and preparation method and application of traditional Chinese medicine preparation
CN107115443A
Traditional Chinese medicine composition for preventing and treating aged cognitive functional disorder and preparation method thereof
CN108404021A
Traditional Chinese medicine composition for treating insomnia after stroke in cerebral infarction recovery period and application thereof
CN112190638A
Traditional Chinese medicine composition for invigorating splenic yang and resolving dampness for new crown pneumonia and preparation method of traditional Chinese medicine composition
CN114392329A
